←
Alexandre Gallerand24 posts
Alexandre Gallerand avatar

Alexandre Gallerand

@AlexGallerand
◷ Joined July 2016
Ivanov lab avatar
⟳ Alexandre Gallerand retweeted
Ivanov lab@IvanovLab·Jun 18

Happy to share our recent review on CD226+ mononuclear phagocytes, published in Trends Open! We share our opinion on the peculiar phenotype of these cells, that share common features with both dendritic cells and macrophages. @LP2M_Lab @CNRS_DR20 cell.com/trends-open/fulltex…

Ivanov lab avatar
⟳ Alexandre Gallerand retweeted
Ivanov lab@IvanovLab·22 Jul 2025

CSF1R regulates monocyte subset differentiation and intracellular metabolism. biorxiv.org/content/10.1101/… Our new preprint is now online ! Here, we explore links between CSF1R signalling, intracellular metabolism and monocyte differentiation.@LP2M_Lab @Cnrs20 @Univ_CotedAzur @Inserm

Ivanov lab avatar
⟳ Alexandre Gallerand retweeted
Ivanov lab@IvanovLab·4 Jun 2025

Congrats @LettieriBarbato and team for their recent publication on brown adipose tissue macrophages, happy to have been involved in the project ! @LP2M_Lab @CNRSbiologie @Univ_CotedAzur @Lab__Williams nature.com/articles/s41467-0…

Maxim Artyomov avatar
⟳ Alexandre Gallerand retweeted
Maxim Artyomov@maxim_artyomov·18 Apr 2025

latest from our lab: ITACONATE MECHANISM SOLVED!! Tom Paulenda @tompaulenda solved molecular mechanism of immunoregulatory action of itaconate in macrophages: nature.com/articles/s42255-0… Previously, our lab has discovered two major immunoregulatory phenotypes of itaconate in macrophages - enhancement of type I interferon signaling and inhibition of late inflammasome activation (Swain et al, 2020 and Bambouskova et al, 2021). Yet the mechanism of immunoregulation itaconate has been elusive even though we (and others) have previously shown its ability to inhibit Sdh and its mild electrophilic properties. In the latest work, we believe we have finally cracked that puzzle!! We show that both immunoregulatory phenotypes are driven by the ability of itaconate to modulate ROS through non-covalent inhibition of the peroxiredoxin 5, mitochondrial peroxide-detoxifying enzyme. We describe major new phenotypes for the pro-interferon action of itaconate in vitro and in vivo and show that Prdx5 inhibiton is sufficient for immunoregulatory action of itaconate and does not require neither Sdh inhibition nor its mild electrophilicity. (1/2)

Post attachment
Ivanov lab avatar
⟳ Alexandre Gallerand retweeted
Ivanov lab@IvanovLab·6 Dec 2024

Excited to share the lab's first preprint ! We previously observed CD226+ macrophages in brown fat that resemble CCR2- and IRF4-dependent peritoneal small Macs, but we didn't know anything about them... biorxiv.org/content/10.1101/…

Alexandre Gallerand avatar
Alexandre Gallerand@AlexGallerand·19 Oct 2024

Ivanov lab paper ! Very happy to see our story on monocyte glucose metabolism online in ⁦@NatureComms⁩ today. Inhibition of Glut1 depletes the majority of blood monocytes, yet atherosclerotic plaques still develop normally🧐 ⁦⁦@LP2M_Lab⁩ nature.com/articles/s41467-0…

Alexandre Gallerand avatar
Alexandre Gallerand@AlexGallerand·14 Jun 2024

Super cool study from @Lab__Williams, happy to have participated along with members of Ivanov lab and @LP2M_Lab Our understanding of adrenal gland macrophages keeps improving 👍

Our latest JCI Insight paper addresses the formation of Trem2+ Lipid Associated Macrophages (LAMs) in the adrenal gland after acute or chronic stress responses: Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGFβ @UMN_IBP insight.jci.org/articles/vie…